Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology

Cytopathology

Volumn 25, Issue 3, 2014, Pages 146-154

  Johnson, S J ^a   Hardy, S A ^b   Roberts, C ^b   Bourn, D ^b   Mallick, U ^a   Perros, P ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

BRAF; Cytology; Fine needle aspiration; FNA; Melt curve analysis; Mutation analysis; Papillary thyroid carcinoma

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

ARTICLE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION RATE; MUTATIONAL ANALYSIS; PILOT STUDY; POORLY DIFFERENTIATED THYROID CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; TUMOR DIFFERENTIATION; UNITED KINGDOM; WILD TYPE; CANCER STAGING; CARCINOMA; DNA DENATURATION; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PATHOLOGY; THYROID GLAND; THYROID NODULE; THYROID TUMOR;

BIOPSY, FINE-NEEDLE; CARCINOMA; CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; NEOPLASM STAGING; NUCLEIC ACID DENATURATION; PROTO-ONCOGENE PROTEINS B-RAF; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 84900863087     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12125     Document Type: Article

References (33)

1. Royal College of Pathologists. Guidance on the Reporting of Thyroid Cytology Specimens. London: Royal College of Pathologists; 2009
2. Ali S, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. Definitions, Criteria and Explanatory Notes. New York: Springer; 2010.
3. Kocjan G, Chandra A, Cross PA et al. The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system. Am J Clin Pathol 2011;135:852-9.
4. Cochand-Priollet B, Schmitt FC, Totsch M et al. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe. Acta Cytol 2011;55:507-11.
5. Kumagai A, Namba H, Hayashi T et al. Clinical implications of pre-operative rapid BRAF analysis for papillary thyroid carcinoma. Endocr J 2007;54:399-405.
6. Bentz BG, Miller BT, Holden JA, Rowe LR, Bentz JS. B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules. Otolaryngol Head Neck Surg 2009;140:709-14.
7. Xing M, Clark D, Guan H et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009;27:2977-82.
8. Canadas-Garre M, Becerra-Massare P, Lopez de la Torre-Casares M et al. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients. Ann Surg 2012;255:986-92.
9. Cochand-Priollet B, Dahan H, Laloi-Michelin M et al. Immunohistochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid 2011;21:1067-73.
10. Rossi E, Martini M, Straccia P et al. The sequential application of immunocytochemistry. BRAF-1 and N-RAS mutation analysis identifies malignant follicular thyroid neoplasms on liquid-based cytology. Acta Cytol 2013;57(suppl1):135, p. 331
11. Rossi ED, Martini M, Capodimonti S et al. Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma. Eur J Endocrinol 2013;168:853-9.
12. Poller D, Glaysher S. Braf V600 co-testing is technically feasible in conventional non-liquid based thyroid FNA cytology smears and can reduce the need for completion thyroidectomy. Cytopathology 2014;25:155-9.
13. Rossi E. Pre-analytic steps for BRAF testing on thyroid fine needle aspirations. Acta Cytol 2013;57(suppl1):11. CM08.4.
14. Rossle M, Zimmerman AK, Zimmerman D, Bode B. Value of immunohistochemical detection of BRAF V600E-mutated protein in fine needle aspiration biopsies of papillary thyroid carcinoma. Acta Cytol 2013;57(suppl1):32. O-27
15. Hardy S, Mallick UK, Perros P et al. Development of molecular testing for thyroid cytology specimens. Cytopathology 2011;22:i-xvi.
16. Nikiforov YE, Steward DL, Robinson-Smith TM et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009;94:2092-8.
17. Proietti A, Giannini R, Ugolini C et al. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. Thyroid 2010;20:1263-70.
18. Min HS, Lee C, Jung KC. Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population. J Korean Med Sci 2013;28:534-41.
19. Lee SR, Jung CK, Kim TE et al. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of ras mutation testing. Thyroid 2013;23:1416-22.
20. Elsheikh TM, Asa SL, Chan JK et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary thyroid carcinoma. Am J Clin Pathol 2008;130:736-44.
21. Liu J, Singh B, Tallini G et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 2006;107:1255-64.
22. Rivera M, Tuttle RM, Patel S et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 2009;19:119-27.
23. Chang HY, Lin JD, Chou SC, Chao TC, Hsueh C. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J Clin Oncol 2006;36:688-93.
24. Kurian EM, Dawlett M, Wang J, Gong Y, Guo M. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol 2012;40(suppl1):E69-E73.
25. Kim SW, Lee JI, Kim JW et al. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 2010;95:3693-700.
26. Marchietti I, Iervasi G, Mazzanti CM et al. Detection of the BRAFV600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual microdissection: an easy tool to improve the pre-operative diagnosis. Thyroid 2012;22:292-8.
27. Domingues R, Mendonça E, Sobrinho L, Bugalho MJ. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma. Cytopathology 2005;16:27-31.
28. Nikiforov YE, Ohori NP, Hodak SP et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011;96:292-8.
29. Yip L, Nikiforova MN, Carty SE et al. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 2009;146:1215-23.
30. Moon WJ, Choi N, Choi JW, Kim SK, Hwang TS. BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. Am J Roentgenol 2012;198:668-74.
31. Moon HJ, Kim EK, Chung WY et al. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration. Ann Surg Oncol 2011;18:792-9.
32. Kim T, Oh YL, Kim KM, Shin JH. Diagnostic dilemmas of hyalinizing trabecular tumours on fine needle aspiration cytology: a study of seven cases with BRAF mutation analysis. Cytopathology 2011;22:407-13.
33. Yip L, Farris C, Kabaker AS et al. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab 2012;97:1905-12.